US EditionWhat TrumpRx May Mean For You
The TrumpRx website will offer an average 50% discount on drugs from Pfizer and others as part of a plan to address high U.S. medication costs by 2026.
- On Tuesday, President Donald Trump announced TrumpRx at the White House with Pfizer CEO Albert Bourla; the White House said it will list Pfizer drugs at 50% discounts, launching in early 2026.
- Promoting Most Favoured Nation pricing, the administration paired new rules with tariff threats and manufacturing incentives, including an executive order signed in May and a 100% import tariff for companies building U.S. manufacturing plants.
- Senior officials note TrumpRx will link consumers to manufacturers' direct-to-consumer channels, not handle distribution, but experts warned discounts rely on cash payments and insurance rules.
- Pfizer agreed to boost U.S. manufacturing in exchange for a three-year tariff exemption, while proposed 100% import tax risks raising costs for Medicare, Medicaid and patients with no insurance.
- Some firms may offer steep discounts on select drugs while adjusting prices elsewhere, critics note, as experts critical of the plan warn drugmakers could raise prices abroad despite Pfizer's deep discounts.
17 Articles
17 Articles
Trump’s solution for high drug prices is a discount portal called TrumpRx
President Donald Trump is launching a new government-run website that he says will let Americans buy medications at lower prices. The new website, called TrumpRx, is expected to launch in 2026 and will direct consumers to discounts on drugmakers’ online stores, including Pfizer’s, as reported earlier by The New York Times and NPR. The Tuesday announcement comes as part of a deal that grants Pfizer a three-year reprieve from tariffs in exchange f…
What is ‘TrumpRx’, website to be launched for discounted drugs?
TrumpRx, which is set to launch in early 2026, will not directly sell or distribute the medicine to consumers. Instead, customers can search for the drugs they want on the website and will then be forwarded to Pfizer’s direct-to-consumer sales. The company said it will sell many of its main drugs and some brand-name drugs at a discount of as much as 50 per cent. However, experts pointed out most of the drugs Pfizer is offering are expensive and …
Coverage Details
Bias Distribution
- 69% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
